U.S. flag

An official website of the United States government

NM_000525.4(KCNJ11):c.149G>T (p.Arg50Leu) AND Transitory neonatal diabetes mellitus

Germline classification:
Likely risk allele (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002227391.2

Allele description [Variation Report for NM_000525.4(KCNJ11):c.149G>T (p.Arg50Leu)]

NM_000525.4(KCNJ11):c.149G>T (p.Arg50Leu)

Gene:
KCNJ11:potassium inwardly rectifying channel subfamily J member 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.1
Genomic location:
Preferred name:
NM_000525.4(KCNJ11):c.149G>T (p.Arg50Leu)
HGVS:
  • NC_000011.10:g.17387943C>A
  • NG_012446.1:g.5717G>T
  • NM_000525.4:c.149G>TMANE SELECT
  • NM_001166290.2:c.-16-97G>T
  • NM_001377296.1:c.-17+75G>T
  • NM_001377297.1:c.-16-97G>T
  • NP_000516.3:p.Arg50Leu
  • NC_000011.9:g.17409490C>A
Protein change:
R50L
Links:
dbSNP: rs80356611
NCBI 1000 Genomes Browser:
rs80356611
Molecular consequence:
  • NM_001166290.2:c.-16-97G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001377296.1:c.-17+75G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001377297.1:c.-16-97G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000525.4:c.149G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Transitory neonatal diabetes mellitus
Synonyms:
Transient neonatal diabetes mellitus
Identifiers:
MONDO: MONDO:0020525; MedGen: C0342273; Human Phenotype Ontology: HP:0008255

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002505947Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
criteria provided, single submitter

(K & H Uppaluri Personalized Medicine Clinic Variant Classification & Assertion Criteria_Updated V.1)
Likely risk allelesomaticresearch

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation.

Peña-Almazan S.

Diabetes Res Clin Pract. 2015 Apr;108(1):e18-20. doi: 10.1016/j.diabres.2014.12.010. Epub 2015 Jan 30.

PubMed [citation]
PMID:
25678012

Water intake disorder in a DEND syndrome afflicted patient with R50P mutation.

Maejima Y, Hasegawa S, Horita S, Kumamoto K, Galvanovskis J, Takenoshita S, Shimomura K.

Endocr J. 2015;62(4):387-92. doi: 10.1507/endocrj.EJ14-0392. Epub 2015 Mar 14.

PubMed [citation]
PMID:
25739471

Details of each submission

From Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic, SCV002505947.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedresearch PubMed (2)

Description

Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. This particular variant (rs80356611) is associated with DEND syndrome.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024